BIG Time for Baby study (scientific name: POSITIVE) is growing fast

Intro text: 


Since its launch in December 2014, the study has been activated in 10 hospitals in 3 different countries: Switzerland, Italy and Australia. Additional sites in Italy, as well as hospitals in Belgium, are expected to join the study this month, and the North American participating hospitals are expected to become active in June.

Four women who have been treated with endocrine therapy for breast cancer and now want to start families have thus far joined the study. Overall, BIG Time for Baby aims to recruit 500 young women to participate.
This study will be an important step in evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with estrogen receptor-positive breast cancer who wish to become pregnant.

Read more about the project